期刊文献+

Akt下游蛋白调控炎症介质表达机制的研究进展 被引量:8

Research advance in the mechanism of Akt downstream protein regulation of inflammatory mediators
下载PDF
导出
摘要 磷酸肌醇3-激酶(PI3K)/丝氨酸苏氨酸蛋白激酶(Akt)信号通路是生物体内重要的信号通路之一,能够调控细胞生长、增殖、凋亡等生物活性。大量研究表明PI3K/Akt信号通路激活可以参与炎症反应、调节免疫应答。Akt是PI3K信号通路的关键下游蛋白,因此研究Akt下游蛋白对休克、脓毒症、缺血再灌注损伤等炎性疾病调控的作用机制,有助于找到治疗该类疾病的潜在靶点。 Phosphoinositol 3-kinase(PI3K)/serine threonine protein kinase(Akt)signaling pathway is one of the important signaling pathways in the body,which can regulate the biological activity of cell growth,proliferation and apoptosis. A large number of studies have shown that activation of PI3K/Akt signaling pathway is involved in inflammatory responses and regulation of immune responses. Akt is a key downstream protein of the PI3 K signaling pathway. Therefore,the mechanism of Akt downstream protein on the regulation of inflammatory diseases such as shock,sepsis and ischemia-reperfusion injury is helpful to find a potential target for the treatment of these diseases.
作者 韩婷婷 史家欣 李小民 Han Tingting;Shi Jiaxin;Li Xiaomin(Li Xiaomin3(Department of Emergency Medicine;Department of Respiratory Medicine, Affiliated Hospital of Xuzhou Medical University;Department of Emergency Medicine, Affiliated Hospital of the Kangda College of NMU, Lianyungang 212002, China)
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2018年第6期853-857,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫计委面上科研课题(H201558) 国家自然科学基金(81300052) 中国博士后科学基金(2015M570420) 连云港市科技局资助(SH1401)
关键词 AKT mTOR GSK-3Β ENOS FOXO1 炎症反应 Akt mTOR GSK-3β eNOS FOXO 1 inflammatory responses
  • 相关文献

参考文献4

二级参考文献47

  • 1肖秀英,于宝华,王丽莎,倪淑娟,杨晓燕,朱玉芬.结直肠癌原发及转移灶中PI3K、p-Akt及mTOR的表达及意义[J].中国癌症杂志,2011,21(4):247-250. 被引量:7
  • 2成志勇,潘崚,牛志云,梁文同,贾志强,颜晓燕,姚丽,杨敬慈.PTEN基因转染对白血病细胞VEGF调控作用的影响[J].肿瘤,2010,30(10):815-821. 被引量:17
  • 3欧阳钦.溃疡性结肠炎临床诊断指南[J].临床消化病杂志,2007,19(1):4-6. 被引量:67
  • 4Chan S. Targeting the mammalian target of rapa- mycin (mTOR): a new approach to treating cancer. Br J Cancer 2004; 91:1420-1424 [PMID: 15365568 DOI: 10.1038/sj.bjc.6602162].
  • 5Wacheck V. roTOR pathway inhibitors in cancer therapy: moving past rapamycin. Pharmacogenomics 2010; 11:1189-1191 [PMID: 20860456 DOI: 10.2217/ pgs.10.113].
  • 6Huang ZF, Massey JB, Via DP. Differential regula- tion of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in human in vitro differ- entiated macrophages. Biochem Pharmacol 2000; 59: 187-194 [PMID: 10810453].
  • 7Paiotti AP, Artigiani Nero R, Forones NM, Oshima CT, Miszputen SJ, Franco M. Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis. Braz J Med Biol Res 2007; 40:911-918 [PMID: 17653443].
  • 8Liu J, Weiss HL, Rychahou P, Jackson LN, Evers BM, Gao T. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene 2009; 28:994-1004 [PMID: 19079341 DOI: 10.1038/onc.2008.450].
  • 9Leo Swadling,Paul Klenerman,Eleanor Barnes.Ever closer to a prophylactic vaccine for HCV[J]. Expert Opinion on Biological Therapy . 2013 (8)
  • 10Mathieu Laplante,David M. Sabatini.mTOR Signaling in Growth Control and Disease[J]. Cell . 2012 (2)

共引文献153

同被引文献80

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部